Court Removes Injunction on Sun Pharma's LEQSELVI Launch in US Farhat Nasim10 April 2025 6:05 PM ISTDelhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction...
Sun Pharma alopecia drug Leqselvi launch blocked in US Farhat Nasim4 Nov 2024 7:05 PM ISTNew Delhi: Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in...
Sun Pharma presents Leqselvi data highlighting clinical efficacy, durability for Alopecia Areata treatment at 2024 Fall Clinical Dermatology Conference Ruchika Sharma28 Oct 2024 11:30 AM ISTMumbai: Sun Pharmaceutical Industries Limited has presented new data highlighting the clinical efficacy and safety of LEQSELVI (deuruxolitinib) 8...
Sun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024 EADV Congress Ruchika Sharma27 Sept 2024 3:51 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio at the 33rd European...
Sun Pharma gets USFDA nod for alopecia areata drug Leqselvi Ruchika Sharma26 July 2024 11:34 AM ISTLEQSELVI is a new, twice daily oral selective inhibitor of Janus Kinases (JAK) JAK1 and JAK2.
